Cargando…

Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment

BACKGROUND: Primary Sjögren syndrome (pSS) is a common autoimmune condition which primarily affects epithelial tissue, often including the kidney causing either tubulointerstitial nephritis (TIN) or more rarely, an immune complex related glomerulonephritis. METHODS: We describe the clinical, biochem...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Rhys D. R., Laing, Christopher M., Ciurtin, Coziana, Walsh, Stephen B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700638/
https://www.ncbi.nlm.nih.gov/pubmed/26728714
http://dx.doi.org/10.1186/s12891-015-0858-x
_version_ 1782408353553580032
author Evans, Rhys D. R.
Laing, Christopher M.
Ciurtin, Coziana
Walsh, Stephen B.
author_facet Evans, Rhys D. R.
Laing, Christopher M.
Ciurtin, Coziana
Walsh, Stephen B.
author_sort Evans, Rhys D. R.
collection PubMed
description BACKGROUND: Primary Sjögren syndrome (pSS) is a common autoimmune condition which primarily affects epithelial tissue, often including the kidney causing either tubulointerstitial nephritis (TIN) or more rarely, an immune complex related glomerulonephritis. METHODS: We describe the clinical, biochemical and histological characteristics of 12 patients with pSS related TIN and their response to treatment with antiproliferative agents. All 12 patients were investigated and treated at the UCL Centre for Nephrology in London. RESULTS: All patients had TIN demonstrated via needle biopsy; immunophenotyping showed that the interstitial infiltrate was predominantly a CD4+ T-cell infiltrate. Urinary acidification testing demonstrated distal renal tubular acidosis in 8 patients. Proximal tubular dysfunction was present in 5 patients. All but 1 patient were treated with antiproliferative agents and most also with a reducing course of steroids. In the treated patients, there was a significant improvement in the serum creatinine and measured GFR. CONCLUSION: Patients with pSS TIN have significant renal impairment and other functional tubular defects. There is a mononuclear lymphocytic infiltrate on renal biopsy and this appears to be mainly a CD4+ T-cell infiltrate. Treatment with mycophenolate (and corticosteroids) improves the renal function in patients with pSS TIN.
format Online
Article
Text
id pubmed-4700638
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47006382016-01-06 Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment Evans, Rhys D. R. Laing, Christopher M. Ciurtin, Coziana Walsh, Stephen B. BMC Musculoskelet Disord Research Article BACKGROUND: Primary Sjögren syndrome (pSS) is a common autoimmune condition which primarily affects epithelial tissue, often including the kidney causing either tubulointerstitial nephritis (TIN) or more rarely, an immune complex related glomerulonephritis. METHODS: We describe the clinical, biochemical and histological characteristics of 12 patients with pSS related TIN and their response to treatment with antiproliferative agents. All 12 patients were investigated and treated at the UCL Centre for Nephrology in London. RESULTS: All patients had TIN demonstrated via needle biopsy; immunophenotyping showed that the interstitial infiltrate was predominantly a CD4+ T-cell infiltrate. Urinary acidification testing demonstrated distal renal tubular acidosis in 8 patients. Proximal tubular dysfunction was present in 5 patients. All but 1 patient were treated with antiproliferative agents and most also with a reducing course of steroids. In the treated patients, there was a significant improvement in the serum creatinine and measured GFR. CONCLUSION: Patients with pSS TIN have significant renal impairment and other functional tubular defects. There is a mononuclear lymphocytic infiltrate on renal biopsy and this appears to be mainly a CD4+ T-cell infiltrate. Treatment with mycophenolate (and corticosteroids) improves the renal function in patients with pSS TIN. BioMed Central 2016-01-05 /pmc/articles/PMC4700638/ /pubmed/26728714 http://dx.doi.org/10.1186/s12891-015-0858-x Text en © Evans et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Evans, Rhys D. R.
Laing, Christopher M.
Ciurtin, Coziana
Walsh, Stephen B.
Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment
title Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment
title_full Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment
title_fullStr Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment
title_full_unstemmed Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment
title_short Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment
title_sort tubulointerstitial nephritis in primary sjögren syndrome: clinical manifestations and response to treatment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700638/
https://www.ncbi.nlm.nih.gov/pubmed/26728714
http://dx.doi.org/10.1186/s12891-015-0858-x
work_keys_str_mv AT evansrhysdr tubulointerstitialnephritisinprimarysjogrensyndromeclinicalmanifestationsandresponsetotreatment
AT laingchristopherm tubulointerstitialnephritisinprimarysjogrensyndromeclinicalmanifestationsandresponsetotreatment
AT ciurtincoziana tubulointerstitialnephritisinprimarysjogrensyndromeclinicalmanifestationsandresponsetotreatment
AT walshstephenb tubulointerstitialnephritisinprimarysjogrensyndromeclinicalmanifestationsandresponsetotreatment